Open AccessModern trends in complex treatment of children with dacryocystitis
Author(s) -
M. R. Ziyozoda,
R. A. Rakhmatova,
Z. N. Nabiev
Publication year - 2021
Publication title -
zdravoohranenie tadžikistana
Language(s) - English
Resource type - Journals
ISSN - 0514-2415
DOI - 10.52888/0514-2515-2021-349-2-53-58
Subject(s) - medicine , dacryocystitis , staphylococcus epidermidis , antibiotics , chronic dacryocystitis , staphylococcus aureus , pediatrics , dermatology , surgery , microbiology and biotechnology , dacryocystorhinostomy , bacteria , biology , genetics
Aim. To assess the effectiveness of modern methods of therapy for children with complicated dacryocystitis. Materials and methods. We have studied the results of clinical observations of 75 children in the Pediatric ophthalmological department of the SI “NMC Shifobakhsh” of the MoHSP of RT. The age of children ranged from 7 days to 3 years. 60 children had chronic and 15 phlegmonous dacryocystitis. Immediately after the patients were admitted to the department, clinical and laboratory studies were carried out before the start of antibiotic therapy, inoculum (the contents of the lacrimal sac) was examined to determine the nature of the microora. Results and discussions . It was found that one of the main causative agents of a purulent inammatory process in children with dacryocystitis is Staphylococcus epidermidis (n = 34; 45.3%) and Staphylococcus aureus (n = 11; 15%). Also, 6 (8.7%) children were diagnosed with mixed infection - association of Staphylococcus epidermidis and Pneumococcus pneumoniae. In 5 (7.3%) cases, the culture was sterile. Conclusion. Thus, the current strategic direction in the antibacterial treatment of these diseases is the use of the latest generation of antibiotics, to which there are few resistant strains. Such medicines include uoroquinolones - levooxacin and ooxacin.